Abstract
Background and Purpose—

The clinical utility of positron emission tomography (PET) imaging in evaluating carotid artery plaque vulnerability remains unclear. Two tracers of recent interest for carotid plaque imaging are
18
F-fluorodeoxyglucose (
18
F-FDG) and
18
F-sodium fluoride (
18
F-NaF). We performed a systematic review and meta-analysis evaluating the association between carotid artery
18
F-FDG or
18
F-NaF uptake and recent or future cerebral ischemic events.



Methods—
A systematic review of Ovid MEDLINE, Ovid EMBASE, and the Cochrane library was conducted from inception to December 2017 for articles evaluating PET tracer uptake in recently symptomatic versus asymptomatic carotid arteries, and articles evaluating carotid uptake in relation to future ischemic events. Cerebral ischemic events were defined as ipsilateral strokes, transient ischemic attacks, or amaurosis fugax. We quantitatively pooled studies by a random-effects model when 3 or more studies were amenable for analysis. We assessed the standardized mean difference between tracer uptake in the symptomatic versus asymptomatic carotid artery using Cohen’s d metric.


Results—

After screening 4144 unique articles, 13 prospective cohort studies assessing carotid artery
18
F-FDG uptake in patients with recent cerebral ischemia were eligible for review. Eleven cohorts of 290 subjects scanned with
18
F-FDG were eligible for meta-analysis. We found that carotid arteries ipsilateral to recent ischemic events had significantly higher
18
F-FDG uptake than asymptomatic arteries (Cohen’s d =0.492; CI=0.130–0.855;
P
=0.008) as well as significant heterogeneity (Cochran’s Q =31.5;
P
=0.0005;
I
2
=68.3%). Meta-regression was not performed due to the limited number of studies in the analysis. Only 2 studies investigating
18
F-NaF PET imaging, and another 2 articles investigating ischemic event recurrence were found.



Conclusions—

Recent ipsilateral cerebral ischemia may be associated with increased carotid
18
F-FDG uptake on PET imaging regardless of degree of carotid stenosis, although significant heterogeneity was found, and these results should be interpreted with caution. Emerging evidence suggests a similar association may be present with
18
F-NaF plaque uptake. More studies are warranted to provide definitive conclusions on the utility of
18
F-FDG or
18
F-NaF in carotid plaque evaluation before investigating carotid PET as a diagnostic tool for cerebral ischemic events.
Topics

No keywords indexed for this article. Browse by subject →

References
47
[36]
Wu, YW, Kao, HL, Chen, MF, Lee, BC, Tseng, WY, Jeng, JS, et al. Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. J Nucl Med. 2007;48:227–233.
[40]
Simvastatin Attenuates Plaque Inflammation

Nobuhiro Tahara, Hisashi Kai, Masatoshi Ishibashi et al.

Journal of the American College of Cardiology 10.1016/j.jacc.2006.03.069
[44]
[47]
Carotid Plaque MRI and Stroke Risk

Ajay Gupta, Hediyeh Baradaran, Andrew D. Schweitzer et al.

Stroke 10.1161/strokeaha.113.002551
Metrics
30
Citations
47
References
Details
Published
Aug 01, 2019
Vol/Issue
50(8)
Pages
2072-2079
Cite This Article
Salama Chaker, Khalid Al-Dasuqi, Hediyeh Baradaran, et al. (2019). Carotid Plaque Positron Emission Tomography Imaging and Cerebral Ischemic Disease. Stroke, 50(8), 2072-2079. https://doi.org/10.1161/strokeaha.118.023987